Products & Services
Applications

Applications

Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
Resources
News Explore
Contact Get started

Oxford Nanopore and NVIDIA collaborate to partner the DGX AI compute system with ultra-high throughput PromethION sequencer

12th January 2021

Oxford Nanopore Technologies and NVIDIA are collaborating this year to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high throughput sequencing system, PromethION. Partnering t...

Read more

20 moments we will remember from 2020

31st December 2020

Dear all, As each year draws to an end, we reflect on its highlights. You can read our 2019 and 2018 blogs here. But 2020 was a year like no other; it's hard to think of the following as highlights...

Read more

Large study in UK NHS labs shows gold-standard accuracy of Oxford Nanopore’s COVID-19 test LamPORE for both symptomatic and asymptomatic patients

21st December 2020

Oxford, 21st December 2020. A study of more than 23,000 samples carried out by teams across the UK shows Oxford Nanopore’s COVID-19 test, LamPORE, is highly accurate for the detection of SARS-CoV-2...

Read more

Oxford Nanopore and SourceBio announce commercial partnership for UK COVID-19 testing service

15th December 2020

Oxford Nanopore’s rapid LamPORE COVID-19 test to be made available via SourceBio accredited lab facilities. Oxford Nanopore Technologies Limited (“Oxford Nanopore”), a leading next generation DNA/...

Read more

At NCM, announcements include single-read accuracy of 99.1% on new chemistry and sequencing a record 10 Tb in a single PromethION run

3rd December 2020

During an update at the 2020 Nanopore Community Meeting, Oxford Nanopore revealed a number of key advances in its sequencing technology. These include the release of new improvements in PromethION ...

Read more

Two new papers further demonstrate the role adaptive sampling could play in understanding genetic disease

30th November 2020

Two new papers published in Nature Biotech today, from teams at the University of Nottingham and Johns Hopkins University, demonstrate the use of real-time nanopore sequencing and adaptive sampling ...

Read more

Introducing the new MinKNOW App

25th November 2020

Today marks the release of the MinKNOW App for iOS and Android devices, now available to download from the Apple Store and Google Play. MinKNOW is the operating software that drives nanopore sequen...

Read more

Structural variation & cancer: top 7 things to read right now

20th November 2020

Somatic mutations are the driving force behind cancer development, and structural variations (SVs) are more and more being recognised as an important class of these mutations. The detection of SVs i...

Read more

Interview: Nanopore sequencing: the mobile methylome

17th November 2020

Adam Ewing leads the Translational Bioinformatics Group at the Mater Research Institute - University of Queensland in Australia, where he works to develop methods and software for analysing high t...

Read more

Structural variation in human genomics: 6 things to read right now

3rd November 2020

The significance of structural variation in human genomics is becoming increasingly established in many fields, from cancer to neurology and the mechanisms of rare disease. With research moving at a...

Read more

Epigenetics, Cas9-mediated enrichment and novel insights in transcriptome variation: catch up on talks from ASHG 2020

30th October 2020

This week we heard from Ariel Gershman, Shruti Iyer and Tuuli Lappalainen on their latest research addressing some of the key challenges in human genomics using nanopore technology. The talks are no...

Read more

Oxford Nanopore announces multiple releases, for high-accuracy, content-rich, high-throughput whole-genome sequencing, and dynamic targeted sequencing

28th October 2020

- announced at the 2020 American Society of Human Genetics (ASHG) Meeting. Oxford, UK, 28th October 2020. Oxford Nanopore announces multiple releases that expand and improve its sequencing techno...

Read more

Your Oxford Nanopore guide to ASHG 2020 online

26th October 2020

ASHG 2020 has moved online this year but there’s still plenty going on and lots of ways you can find out about how human genomics researchers are overcoming some of the big challenges in the field...

Read more

Blog: cuteSV - a powerful tool to uncover the full spectrum of genomic structural variants

19th October 2020

In this blog, Tao Jiang describes his work on the development of the structural variant (SV) caller cuteSV. Read on to find out how the cuteSV bioinformatics pipeline works, how it performs relative...

Read more

Oxford Nanopore announces £84.4M in new capital

13th October 2020

Oxford, UK: Oxford Nanopore Technologies has raised £84.4M in new capital. The funding comes from existing investors and new investors, including International Holdings Company (IHC), RPMI Railpen...

Read more

Oxford Nanopore, the Bill and Melinda Gates Foundation, Africa Centres for Disease Control and Prevention and other partners collaborate to transform disease surveillance in Africa

12th October 2020

Oxford Nanopore, the Bill & Melinda Gates Foundation, US CDC, Microsoft and Illumina collaborate with the Africa Centres for Disease Control and Prevention (Africa CDC) to launch Africa Pathogen...

Read more

LamPORE test for SARS-CoV-2 detection gains CE-IVD mark

9th October 2020

LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a palm-sized de...

Read more

Interview: Improving structural variant interpretation for hereditary cancer susceptibility

5th October 2020

Accurate molecular diagnosis of cancer-causing germline variants enables increased screening, early detection, prevention, and optimal treatment, if cancer does arise in predisposed patients and t...

Read more

Oxford Nanopore welcomes Dr Guy Harmelin as a non-executive Director

2nd October 2020

Guy has extensive experience in healthcare and technology investment and entrepreneurship. He was previously on the leadership team at Harel Insurance Investments and Financial Services, the largest...

Read more

Blog: Copy number variation analysis from plasma: is it feasible using nanopore sequencing?

29th September 2020

In this blog, Filippo Martignano shares his research into copy number variation (CNV) analysis in cancer, from cell-free DNA samples, using shallow whole-genome sequencing. Read on to hear why he ch...

Read more

LamPORE evaluation study shows 99.1% sensitivity, 99.6% specificity

25th September 2020

Scientists from the University of Oxford’s Nuffield Department of Medicine, Public Health England Porton Down (PHE), the University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust ha...

Read more

Targeted sequencing with Oxford Nanopore: Fast, flexible, PCR-free Cas9 Sequencing Kit now available in store

16th September 2020

New Cas9 Sequencing Kit provides reagents for one-stop targeted sequencing, enabling scientists to cost-effectively sequence previously inaccessible target regions. Cas9 targeted sequencing with...

Read more

Blog: Resolving structural variants causing antithrombin deficiency

14th September 2020

In this blog, Alba Sanchis-Juan, Javier Corral, and Belén de la Morena-Barrio describe their research into the genetic basis of thrombophilia, and how nanopore long sequencing reads were needed to r...

Read more

Blog: Revealing the impact of structural variants on cancer susceptibility

2nd September 2020

In this blog, Katherine Dixon shares her team’s work on identifying structural variants in cancer genomes, and she explains why identifying them accurately is so important. Katherine DixonI am a...

Read more
Open a chat to talk to our sales team
FAQs

FAQs

Search